JFGIW
IGC icon

Johnson Financial Group Inc (Wisconsin)’s IGC Pharma IGC Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Hold
1
– – ﹤0.01% 815
2026
Q1 		$1 Buy
+1
New – ﹤0.01% 888

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $145M AUM 29.71% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s IGC Position: Q2 2026 in Review

Johnson Financial Group Inc (Wisconsin) held its IGC Pharma (IGC) position steady in Q2 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #815.

Johnson Financial Group Inc (Wisconsin) first reported a position in IGC in Q1 2026 and has held it in 2 quarters since. 36 funds tracked by Wall St. Rank hold IGC as of Q2 2026.

  • Johnson Financial Group Inc (Wisconsin) held 1 share of IGC Pharma worth $1 as of Q2 2026.
  • Johnson Financial Group Inc (Wisconsin) left its IGC Pharma share count unchanged in Q2 2026.
  • IGC Pharma made up ﹤0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q2 2026, its #815 holding.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in IGC Pharma in Q1 2026 and has held it in 2 quarters since.
  • 36 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.